FDA-cleared profile

CoLumbo C-Spine

Smart Soft Healthcare AD

CoLumbo C-Spine is an image post-processing and measurement software tool that provides quantitative spine measurements from previously-acquired DICOM cervical spine Magnetic Resonance (MR) images for users' review, analysis, and interpretation. It provides the following functionality to assist users in visualizing, measuring and documenting out-of-range measurements: Segmentation of the vertebrae (C3-C7) and disks (C2C3-C7T1); Measurements based on the segmentation; Threshold-based labeling of out-of-range measurement; and Export of measurement results. CoLumbo C-Spine does not produce or recommend any type of medical diagnosis or treatment. The device outputs are intended to be a starting point for a clinical workflow and should not be interpreted or used as a diagnosis. Instead, CoLumbo C-Spine simply helps users to more easily identify and classify features in cervical MR images and potentially compile a report. The user is responsible for confirming/modifying settings, reviewing the software-generated measurements, utilizing CoLumbo C-Spine's output using their medical judgment and discretion. The device is intended to be used only by hospitals and other medical institutions. Only DICOM MR images of the spine of patients aged 22 and above with adequate visualization of C2-C7 are considered to be valid input. Performance has not been established in the presence of vertebral enumeration variants that may interfere with reliable vertebral counting, including true cervical ribs, hemivertebrae, congenital or acquired vertebral fusion, for images acquired with contrast media, for cases involving tumors, infections, post-operative changes, or vertebral fusion, or for examinations in which the C2 vertebra is not adequately visualized.

Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.

Clinical fit

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
CoLumbo C-Spine is an image post-processing and measurement software tool that provides quantitative spine measurements from previously-acquired DICOM cervical spine Magnetic Resonance (MR) images for users' review, analysis, and interpretation. It provides the following functionality to assist users in visualizing, measuring and documenting out-of-range measurements: Segmentation of the vertebrae (C3-C7) and disks (C2C3-C7T1); Measurements based on the segmentation; Threshold-based labeling of out-of-range measurement; and Export of measurement results. CoLumbo C-Spine does not produce or recommend any type of medical diagnosis or treatment. The device outputs are intended to be a starting point for a clinical workflow and should not be interpreted or used as a diagnosis. Instead, CoLumbo C-Spine simply helps users to more easily identify and classify features in cervical MR images and potentially compile a report. The user is responsible for confirming/modifying settings, reviewing the software-generated measurements, utilizing CoLumbo C-Spine's output using their medical judgment and discretion. The device is intended to be used only by hospitals and other medical institutions. Only DICOM MR images of the spine of patients aged 22 and above with adequate visualization of C2-C7 are considered to be valid input. Performance has not been established in the presence of vertebral enumeration variants that may interfere with reliable vertebral counting, including true cervical ribs, hemivertebrae, congenital or acquired vertebral fusion, for images acquired with contrast media, for cases involving tumors, infections, post-operative changes, or vertebral fusion, or for examinations in which the C2 vertebra is not adequately visualized.
Public source Exact FDA submission Checked 2026-09-01

Exact-submission indication text from the ACR AI Central model card. FDA labeling remains controlling.

Intended users
Radiologist, spine surgeon, and neuro-surgeon; hospitals and other medical institutions
Public source Exact FDA submission Checked 2026-09-01

Intended-user text reported in the exact-submission ACR model card.

Care setting and population
Adult
Public source Exact FDA submission Checked 2026-09-01

Patient-population text reported in the exact-submission ACR model card; institutional setting may still require vendor confirmation.

Workflow role
Segmentation or contouring
Public source Exact FDA submission Checked 2026-09-01

Conservative normalization of explicit wording in an exact-submission source.

Required input
MR images or data. Inclusion criteria: DICOM MR images of the cervical spine of patients aged 22 and above with adequate visualization of C2-C7
Public source Exact FDA submission Checked 2026-09-01

Conservative normalization of explicit wording in an exact-submission source.

Output and human action
The software outputs segmentation of vertebrae (C3-C7) and disks (C2C3-C7T1), quantitative measurements based on segmentation (vertebral body height, disk height, disk material outside intervertebral space AP size, focal disk material outside intervertebral space AP size), threshold-based labeling of out-of-range measurements, and export of measurement results. Outputs serve as a starting point for clinical workflow and are not intended as a diagnosis.
Public source Exact FDA submission Checked 2026-09-01

Clinical output reported in the exact-submission ACR model card.

Limitations
Exclusion criteria: Vertebral enumeration variants that may interfere with reliable vertebral counting including true cervical ribs, hemivertebrae, congenital or acquired vertebral fusion; images acquired with contrast media; cases involving tumors, infections, post-operative changes, or vertebral fusion; examinations in which the C2 vertebra is not adequately visualized; pregnant patients
Public source Exact FDA submission Checked 2026-09-01

Limitations and supported-acquisition details reported in the exact-submission ACR model card.

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K254015
FDA source Exact FDA submission Checked 2026-08-31
Modality
MRI
Public source Exact FDA submission Checked 2026-09-01

Imaging modality reported in the exact-submission ACR AI Central model card.

Anatomy
Spine
Public source Exact FDA submission Checked 2026-09-01

Anatomy normalized from explicit exact-submission ACR model-card wording.

Clearance type
510(k)
FDA source Exact FDA submission Checked 2026-08-31
Decision date
2026-04-01
FDA source Exact FDA submission Checked 2026-08-31
FDA status
FDA-cleared
FDA source Exact FDA submission Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
The exact-submission ACR model card explicitly references DICOM in the described input, output, or workflow; exact interfaces, versions, and local compatibility require confirmation.
Public source Exact FDA submission Checked 2026-09-01

Interoperability terms explicitly reported in the exact-submission ACR model card; interface versions and local compatibility still require confirmation.

Deployment and data flow
Research pending
Needs research Exact FDA submission Checked 2026-08-31

Attach an exact-product deployment and data-flow source.

Security and privacy
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13

FDA authorization does not establish the current commercial security posture. Request data-flow diagrams, hosting and retention details, access controls, audit logging, attestations, and incident-response documentation.

Training and support
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13

Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.

Monitoring and change control
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13

Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.

Input or output interoperability

DICOM is explicitly referenced in the described input, output, or workflow.

exact submission · checked 2026-09-01

The model card does not establish every supported DICOM object, transfer method, or local interface.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.

Evidence summary
Study type: Stand-Alone Performance. Cases: 95
Public source Exact FDA submission Checked 2026-09-01

Structured study metadata from the exact-submission ACR model card; this is not an independent evidence synthesis.

Reported sensitivity
Research pending
Needs research Exact FDA submission Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
Needs research Exact FDA submission Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

CoLumbo C-Spine regulatory performance study summary

Stand-Alone Performance · Adult

exact submission · Tested version: Exact product version not reported; regulatory study summarized for FDA submission K254015 · n=95 · Independence not established

K254015

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Economics and lifecycle

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-08-13

FDA submission materials do not establish current commercial pricing. Request the pricing unit, term, minimum commitment, implementation fees, and included support from the vendor.

Reimbursement and coding
Research pending
Needs research Exact FDA submission Checked 2026-08-31

Determine whether any product-specific CPT/HCPCS pathway exists and separate it from billing for the underlying imaging service.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Automated sources checkedStatus
2026-09-04Last searched
17Fields reviewed
5Source classes checked
0Unreviewed PubMed leads
0Unreviewed trial leads
0Unreviewed FDA recall leads

Exact-submission ACR model-card fields were normalized under the current provenance rules; vendor and independent-study confirmation remain distinct. Automated exact-name discovery found 0 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads remain unpublished until a human confirms the exact product and tested version.

Source classes: fda ai list, acr ai central product, pubmed, clinical trials, openfda device recall

Sources

Source ledger

Sources accessed through 2026-09-02.

Alternatives

Related tools to compare

FDA-cleared K242607

ScanDiags Ortho L-Spine MR-Q

ScanDiags AG

FDA product code QIH identifies this device class as Automated Radiological Image Processing Software. To provide automated radiological image processing and analysis tools....

Modality
MRI
Anatomy
Spine
Decision
2025-02-21
FDA-cleared K241108

RemedyLogic AI MRI Lumbar Spine Reader

Remedy Logic Inc.

FDA product code QIH identifies this device class as Automated Radiological Image Processing Software. To provide automated radiological image processing and analysis tools....

Modality
MRI
Anatomy
Spine
Decision
2024-10-30
FDA-cleared K241329

SubtleSYNTH (1.x)

Subtle Medical, Inc.

SubtleSYNTH is a software medical device consisting of a machine-learning algorithm that synthesizes a SynthSTIR contrast image from T1-weighted and T2-weighted spine MR images.

Modality
MRI
Anatomy
Spine
Decision
2024-07-11
FDA-cleared K180091

UNiD Spine Analyzer

Medicrea International

FDA product code LLZ identifies this device class as System, Image Processing, Radiological. Consult the linked FDA record for the exact authorized indications for use.

Modality
MRI
Anatomy
Spine
Decision
2018-02-08